Disease Control Efficacy of Ductal Carcinoma In Situ (DCIS) Treated With Accelerated Partial Breast Irradiation (APBI)

被引:1
|
作者
Lei, R. Y. [1 ,2 ]
Leonard, C. E. [2 ]
Howell, K. T. [2 ]
LaPorte, R. M. [3 ]
Henkenberns, P. L. [2 ]
Fryman, S. P. [1 ,2 ]
Higdon, R. D. [1 ]
Widner, J. L. [4 ]
Barke, L. D. [5 ]
Carter, D. L. [2 ]
机构
[1] Rocky Mt Canc Ctr, Aurora, CO USA
[2] Rocky Mt Canc Ctr, Littleton, CO USA
[3] Rocky Mt Canc Ctr, Thornton, CO USA
[4] SurgOne, Greenwood Village, CO USA
[5] Invis Sally Jobe Diagnost Breast Ctr, Greenwood Village, CO USA
关键词
D O I
10.1016/j.ijrobp.2013.06.506
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S196 / S196
页数:1
相关论文
共 50 条
  • [1] Accelerated partial breast irradiation (APBI) for ductal carcinoma in situ
    O'Brien, Diana A. Roth
    Boe, Lillian A.
    Mueller, Boris
    Cuaron, John J.
    Xu, Amy
    Bernstein, Michael B.
    McCormick, Beryl
    Powell, Simon N.
    Khan, Atif J.
    Braunstein, Lior Zvi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Propensity-score matched pair comparison of accelerated partial breast irradiation (APBI) and whole breast irradiation (WBI) for ductal carcinoma in situ (DCIS).
    Ben Wilkinson, John
    Fowler, Ashley
    Marina, Ovidiu
    Wallace, Michelle
    Marvin, Kimberly
    Grills, Inge S.
    Brabbins, Donald S.
    Chen, Peter Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Accelerated Partial-Breast Irradiation (APBI) for Ductal Carcinoma in Situ (DCIS): Outcomes from a Single-Institution Prospective Registry
    Brenneman, R.
    Kennedy, W. R.
    Ochoa, L. L.
    Zoberi, J. E.
    Thomas, M. A.
    Zoberi, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E13 - E13
  • [4] Should Ductal Carcinoma In Situ (DCIS) be Removed From the ASTRO Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients With DCIS treated With APBI
    Shah, C. S.
    Vicini, F.
    Wilkinson, J.
    Keisch, M.
    Beitsch, P.
    Lyden, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S86 - S86
  • [5] ACCELERATED PARTIAL BREAST IRRADIATION FOR PURE DUCTAL CARCINOMA IN SITU
    Park, Sean S.
    Grills, Inga Siiner
    Chen, Peter Y.
    Kestin, Larry L.
    Ghilezan, Michel I.
    Wallace, Michelle
    Martinez, Alvaro M.
    Vicini, Frank A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 403 - 408
  • [6] Should Ductal Carcinoma-in-situ (DCIS) Be Removed from the ASTRO Consensus Panel Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients with DCIS Treated with APBI
    Vicini, Frank
    Shah, Chirag
    Ben Wilkinson, J.
    Keisch, Martin
    Beitsch, Peter
    Lyden, Maureen
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (04) : 1275 - 1281
  • [7] Should Ductal Carcinoma-in-situ (DCIS) Be Removed from the ASTRO Consensus Panel Cautionary Group for Off-protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients with DCIS Treated with APBI
    Frank Vicini
    Chirag Shah
    J. Ben Wilkinson
    Martin Keisch
    Peter Beitsch
    Maureen Lyden
    [J]. Annals of Surgical Oncology, 2013, 20 : 1275 - 1281
  • [8] Outcomes for Accelerated Partial Breast Irradiation in Ductal Carcinoma In Situ Patients
    Limbacher, A. L.
    Park, S.
    Grills, I.
    Kestin, L.
    Ghilezan, M.
    Chen, P.
    Wallace, M.
    Lee, D.
    Martinez, A.
    Vicini, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S239 - S239
  • [9] Accelerated partial breast irradiation (APBI)
    Ana Manterola Burgaleta
    Gemma Asín Felipe
    Fernando Arias de la Vega
    [J]. Clinical and Translational Oncology, 2022, 24 : 1657 - 1658
  • [10] Accelerated partial breast irradiation (APBI)
    Burgaleta, Ana Manterola
    Felipe, Gemma Asin
    de la Vega, Fernando Arias
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (08): : 1657 - 1658